I am very hopeful that we will, in this Congress, be able to repeal the Medical Device Tax.

My question is, is it your view that this additional layer of tax that we impose on your industry, on top of the highest corporate income tax rate in the world, does that discourage the attraction of capital by this industry? Does that…

We have to be globally competitive in our corporate tax rates, and this does not help us at all.

Thank you, Ms. Donisvitch.

the Medical Device Tax is the proverbial straw that is breaking the backs of the medical device industry by dissuading innovation.

Excise tax is one of the most egregious taxes ever dreamed up by any form of government.

this tax on sales is going to threaten America's global leadership in this space.

But the medical device tax does not create jobs or grow the economy.

I respectfully ask that the Senate take up and pass S. 149, the Medical Device Access and Innovation Protection Act, authored by Senators Hatch and Klobuchar.

it is my strong belief that Congress should act swiftly to repeal this excise tax to keep health care costs low for American patients, protect innovation, and protect American businesses.

this tax, instead of creating meaningful tax revenues as was its original purpose, has had the unintended consequence of dissuading institutional investment and discouraging entrepreneurship in a vital industry already under significant…

My view is that the medical device tax is not only onerous in its scale, but it is bad in its design.

I want to thank both of you for holding this important hearing highlighting the negative impact the medical device tax is having on American jobs, innovation and patients.

Is it your view that a working-class family benefits from the availability of an affordable choice of whatever the product might be that might originate overseas?

Yes. We are a very large manufacturing State. If we can manufacture more and sell more overseas, I think that follows.

If TPA is passed, and subsequent to that we can pass TPP, is it your view that Pennsylvania farmers will export more products than they otherwise would?

FSOC's 2014 annual report notes that the Council is charged with promoting market discipline by eliminating the expectation of bailouts in the event of a failure of a large financial company.

Wouldn't it be better to apply 'modified' treatment of the LCR, or other rules, to banks of similar operational activities or risk profiles, even if their sizes differ substantially?

I would just urge you to consider the impact of savers losing their purchasing power.

The crisis has been over for a long time. And it is not as though there is no price to be paid by having this unbelievably accommodative policy.

Our offices are frequented by small banks and credit unions who are struggling under a regulatory regime that hasn't been 'right-sized' for them.

We must not forget that more than 400 banks with less than $1 billion in assets failed as a result of the crisis.

We will not be successful this Congress in providing regulatory relief if our proposals do not have broad bipartisan agreement.

While I am very frustrated with the current regulatory framework for our community financial institutions, I am encouraged by our regulators' willingness to appear today and address some of these issues head-on.

I not only want to thank you for holding this hearing but I also want to take the opportunity to thank the panel of regulators for agreeing to appear before the Committee.